Home » Stocks » SNBP

Sun BioPharma, Inc. (SNBP)

Dec 2, 2020 - Stock symbol was changed to PBLA
Stock Price: $3.45 USD 0.00 (0.00%)
Updated Dec 1, 2021 4:00 PM EST
Market Cap 33.58M
Revenue (ttm) n/a
Net Income (ttm) -4.86M
Shares Out 7.89M
EPS (ttm) -0.70
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day Dec 1, 2021
Last Price $3.45
Previous Close $3.45
Change ($) 0.00
Change (%) 0.00%
Day's Open 3.36
Day's Range 3.36 - 3.52
Day's Volume 32,259
52-Week Range 2.49 - 3.61

News

GlobeNewsWire - 1 month ago

MINNEAPOLIS, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (Nasdaq: SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients w...

Other stocks mentioned: PBLA

About SNBP

Sun BioPharma, a clinical-stage biopharmaceutical company, engages in developing therapeutics treatment for unmet medical needs. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. Sun BioPharma, Inc. was founded in 2011 and is based in Waconia, Minnesota.

Industry
Biotechnology
Founded
2011
CEO
Michael Cullen
Employees
4
Stock Exchange
NASDAQ
Ticker Symbol
SNBP
Full Company Profile

Financial Performance

Financial Statements